| 12-month Sales (Billions of $US) | |
|---|---|
| Abilify | 6.4 |
| Nexium | 6 |
| Cymbalta | 5.4 |
| Humira | 5.4 |
| Crestor | 5.3 |
| Advair Diskus | 5.1 |
| Enbrel | 4.7 |
| Remicade | 4 |
| Copaxone | 3.8 |
| Neulasta | 3.5 |
Sources:
webmd.com
Share:
| 12-month Sales (Billions of $US) | |
|---|---|
| Abilify | 6.4 |
| Nexium | 6 |
| Cymbalta | 5.4 |
| Humira | 5.4 |
| Crestor | 5.3 |
| Advair Diskus | 5.1 |
| Enbrel | 4.7 |
| Remicade | 4 |
| Copaxone | 3.8 |
| Neulasta | 3.5 |
A new report looks at the top 100 selling drugs in the U.S. over a 12-month period. The antipsychotic drug Abilify racked up the highest sales with nearly $6.4 billion. Abilify is prescribed to treat schizophrenia, depression, and bipolar disorder. In 3rd place was Cymbalta, also used to treat depression.